Scientists at the Leibniz Institute of Photonic Technology (Leibniz IPHT) have developed a new microarray-based diagnostic ...

Genomics company Illumina (NASDAQ:ILMN) beat Wall Street’s revenue expectations in Q3 CY2025, but sales were flat year on ...

Northwestern Medicine scientists have discovered how a specific transcription factor promotes genetic reprogramming and ...

About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...

A new trial shows that a wireless subretinal implant, the PRIMA system, restored central vision in patients with geographic ...

Imagine slowly losing the center of your vision, like a camera lens fading to fog. That's what happens with geographic ...

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that results from a sex-specific analysis of 160 real-world ...

This report provides a comprehensive analysis of the next-generation proteomics market, highlighting key trends, drivers and ...

Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that Dr. Peter Monteleone will present data from a sex-specific ...

A wireless photovoltaic implant shows promise in restoring central vision for patients with macular degeneration, enhancing visual acuity and independence.